REG-BARCLAYS PLC Form 8.3 - WILLIS TOWERS WATSON PLC AMENDMENT
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20201224:nBw9MnF3Wa&default-theme=true
Form 8.3 - WILLIS TOWERS WATSON PLC AMENDMENT
Ap19
FORM 8.3 Amendment to Purchase and Sales
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER
RULES, 2013
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR
MORE
1. KEY INFORMATION
Name of person dealing (Note 1) Barclays PLC.
Company dealt in WILLIS TOWERS WATSON PLC
Class of relevant security to which the ORD
dealings being disclosed relate (Note 2)
Date of dealing 18 December 2020
2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant
security dealt in (Note 3)
Class of relevant security: ORD
Long Short
Number (%) Number (%)
(1) Relevant securities
3,042,617 2.36% 687,711 0.53%
(2) Derivatives (other than options):
365,705 0.28% 739,005 0.57%
(3) Options and agreements to
purchase/sell: 0 0.00% 0 0.00%
TOTAL:
3,408,322 2.64% 1,426,716 1.11%
(b) Interests and short positions in relevant securities of the company, other
than the class dealt in (Note 3)
Class of relevant security: Long Short
Number (%) Number (%)
(1) Relevant securities
(2) Derivatives (other than options)
(3) Options and agreements to purchase/sell
Total
Ap20
1. DEALINGS (Note 4)
(a) Purchases and sales
Purchase/sale Number of relevant securities Price per unit
Purchase 3 207.0666 USD
Purchase 4 205.5700 USD
Purchase 6 205.8683 USD
Purchase 7 205.5985 USD
Purchase 8 205.3306 USD
Purchase 8 211.7300 USD
Purchase 12 208.8733 USD
Purchase 17 206.7205 USD
Purchase 19 207.8926 USD
Purchase 30 208.6100 USD
Purchase 33 205.4419 USD
Purchase 62 208.7100 USD
Purchase 114 206.4570 USD
Purchase 200 207.4450 USD
Purchase 200 208.5795 USD
Purchase 215 206.5716 USD
Purchase 300 205.8384 USD
Purchase 313 206.1710 USD
Purchase 325 207.8860 USD
Purchase 349 208.1731 USD
Purchase 354 208.3057 USD
Purchase 389 205.4982 USD
Purchase 400 207.7150 USD
Purchase 431 207.1828 USD
Purchase 458 207.7859 USD
Purchase 464 207.4819 USD
Purchase 529 207.9205 USD
Purchase 580 205.1109 USD
Purchase 594 205.9687 USD
Purchase 871 207.9567 USD
Purchase 893 208.7642 USD
Purchase 952 207.0282 USD
Purchase 1,037 206.4791 USD
Purchase 1,088 207.5968 USD
Purchase 2,514 206.0158 USD
Purchase 2,644 205.6038 USD
Purchase 2,695 212.2300 USD
Purchase 2,905 206.0673 USD
Purchase 3,377 205.9469 USD
Purchase 3,783 207.2172 USD
Purchase 5,186 206.7486 USD
Purchase 6,277 206.9416 USD
Purchase 7,416 206.3362 USD
Purchase 10,154 206.6048 USD
Purchase 12,644 206.9919 USD
Purchase 14,511 206.7689 USD
Purchase 15,321 206.2556 USD
Purchase 15,364 206.1043 USD
Purchase 32,519 204.8900 USD
Purchase 124,331 205.1167 USD
Sale 27 205.5200 USD
Sale 38 207.8926 USD
Sale 100 209.5300 USD
Sale 115 209.5704 USD
Sale 118 212.2300 USD
Sale 141 204.8854 USD
Sale 500 205.8780 USD
Sale 500 207.0760 USD
Sale 550 207.1854 USD
Sale 579 206.7461 USD
Sale 610 205.2267 USD
Sale 650 205.7876 USD
Sale 700 207.0464 USD
Sale 700 206.4742 USD
Sale 718 206.7057 USD
Sale 800 206.6343 USD
Sale 1,112 205.2521 USD
Sale 1,200 206.3025 USD
Sale 1,800 205.9866 USD
Sale 2,195 204.9869 USD
Sale 2,315 206.5707 USD
Sale 2,982 206.9378 USD
Sale 3,946 207.2245 USD
Sale 4,071 206.6005 USD
Sale 4,888 205.8335 USD
Sale 8,915 206.4918 USD
Sale 9,074 207.4871 USD
Sale 11,543 207.1036 USD
Sale 23,610 206.9968 USD
Sale 25,549 206.0639 USD
Sale 32,358 204.8900 USD
Sale 127,576 205.1236 USD
(b) Derivatives transactions (other than options transactions)
Product name, Nature of transaction Number of relevant securities Price per unit
e.g. CFD (Note 6) (Note 7) (Note 5)
(c) Options transactions in respect of existing relevant securities
(i) Writing, selling, purchasing or varying
Product name, Writing, selling, purchasing, varying etc. Number of securities to which the option relates (Note 7) Exercise price Type, e.g. American, European etc. Expiry date Option money paid/received per unit (Note 5)
e.g. call option
(ii) Exercising
Product name, Number of securities Exercise price per unit (Note 5)
e.g. call option
(d) Other dealings (including transactions in respect of new securities) (Note
4)
Nature of transaction Details Price per unit
(Note 8) (if applicable) (Note 5)
Ap21
2. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person
disclosing and any other person relating to the voting rights of any relevant
securities under any option referred to on this form or relating to the voting
rights or future acquisition or disposal of any relevant securities to which
any derivative referred to on this form is referenced. If none, this should be
stated.
None-
Is a Supplemental Form 8 (Open Positions) attached? NO
Date of disclosure: 24 Dec 2020
Contact name: Large Holdings Regulatory Operations
Telephone number: 020 3134 7213
If a connected EFM, name of offeree/offeror with which connected
If a connected EFM, state nature of connection
View source version on businesswire.com:
https://www.businesswire.com/news/home/20201224005057/en/
(https://www.businesswire.com/news/home/20201224005057/en/)
BARCLAYS PLC
Copyright Business Wire 2020Recent news on Barclays
See all newsREG - Stock Exch Notice - Admission to Trading - 03/03/2026
AnnouncementREG - Barclays PLC Senior PLC - Form 8.3 SENIOR PLC
AnnouncementREG - Barclays PLC British Land Co PLC - Form 8.3 BRITISH LAND COMPANY PLC, THE
AnnouncementREG - Barclays PLC Wood Group (John)PLC - Form 8.3 WOOD GROUP (JOHN) PLC
AnnouncementREG - Barclays PLC Spire Healthcare Grp - Form 8.3 SPIRE HEALTHCARE GROUP PLC
Announcement